The Biology of Sneddon Syndrome and Its Look-Alikes

Sneddon syndrome is often described as a “clinical diagnosis,” meaning doctors identify it by looking at your symptoms, medical history, and imaging rather than relying on a single definitive test ^[1]. To understand why it happens, it helps to look at the biology of your blood vessels and how they differ from other similar conditions.

How Vessel Blockage Can Occur

In Sneddon syndrome, the problem lies within the small and medium-sized arteries in your skin and brain. It is classically characterized as a non-inflammatory occlusive vasculopathy ^[1][2].

• Vasculitis (The Inflammatory Look-alike): In primary vasculitis, the wall of the blood vessel itself becomes red, swollen, and inflamed because the immune system is actively attacking it ^[3].
• Sneddon Syndrome (Non-Inflammatory): In Sneddon syndrome, the vessel wall isn’t classically inflamed in that way. Instead, the inner lining of the vessel slowly thickens, or tiny blood clots form and get stuck. Over time, these blockages (occlusions) restrict the flow of blood, which can lead to the persistent skin changes and increase the risk of strokes ^[1][4].

Because the vessels aren’t typically inflamed in the traditional sense, common blood tests for inflammation (like Erythrocyte Sedimentation Rate [ESR] or C-Reactive Protein [CRP]) often come back normal. However, normal inflammatory markers do not definitively rule out vasculitis or other conditions, and interpretation always requires a specialist’s clinical judgment ^[4][3].

The Role of Antibodies: aPL-Positive vs. aPL-Negative

Doctors typically divide Sneddon syndrome into two broad groups based on blood tests for antiphospholipid antibodies (aPL), which are immune proteins associated with an increased risk of blood clots ^[1][4].

• aPL-Positive: Some patients test positive for these antibodies. However, a positive test alone does not mean you have Antiphospholipid Syndrome (APS). APS is a distinct diagnosis that generally requires an appropriate clinical event (like a specific type of blood clot or pregnancy complication) plus qualifying antibody results that remain persistently positive on repeat testing at least 12 weeks apart. The type, level, and persistence of the antibodies matter deeply for your individualized treatment plan ^[5][6]. In cases of confirmed APS, doctors may lean towards specific blood thinners because the risk of future clots can be higher ^[7][8].
• aPL-Negative: Many patients have no identifiable antiphospholipid antibodies ^[9]. Research suggests that the core symptoms—like the skin pattern and the risk of recurrent strokes—are broadly similar regardless of antibody status, though treatment approaches may differ ^[4].

Telling It Apart from “Look-alikes”

Because Sneddon syndrome is so rare, doctors must rule out several other conditions that cause similar skin patterns or early strokes. These conditions overlap clinically, and differentiating them requires a specialist’s interpretation of imaging, biopsies, and genetic tests.

CADASIL

CADASIL is an inherited genetic condition that causes strokes and cognitive decline. While it also affects small blood vessels in the brain, it usually does not cause the persistent net-like skin pattern (livedo racemosa) seen in Sneddon syndrome ^[10][11]. Doctors often distinguish CADASIL using genetic testing or by identifying suggestive (though not definitive) white-matter patterns on a brain MRI ^[11][12].

DADA2 (Deficiency of ADA2)

DADA2 is an inherited condition that can cause livedo racemosa and strokes ^[10][13]. While it often starts in childhood, adult presentations exist. DADA2 can include systemic signs like recurrent fevers or an enlarged spleen ^[14]. It is diagnosed through genetic testing or by measuring the activity of the ADA2 enzyme in the blood ^[14][15].

Lymphocytic Thrombophilic Arteritis (LTA)

LTA (sometimes called macular arteritis) can cause a skin pattern that looks nearly identical to Sneddon syndrome. However, LTA is generally considered a skin-only condition and is not typically associated with the progressive neurological impairment or strokes that define Sneddon syndrome ^[16][17].

Primary Antiphospholipid Syndrome (APS)

While aPL-positive Sneddon syndrome is closely related to APS, they are evaluated differently. Standard APS can cause clots anywhere in the body (like the deep veins of the legs or the lungs) and is defined by strict clinical and laboratory criteria ^[5][6].

(Note: This table is a simplified orientation tool. Symptoms and test results vary widely, and final diagnosis requires comprehensive specialist evaluation.)